National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

atvogen
A synthetic derivative of inosinic acid with antiretroviral and immunomodulatory activities. Atvogen acts through a number of pathways to stimulate the antiviral activity of the immune system. This agent stimulates interferon production; activates the oligoadenylate synthase-RNase L pathway; stimulates natural killer cell activity; and acts as a non-mitogenic stimulator of the immune system. Atvogen also inhibits replication of the human immunodeficiency virus (HIV) in vitro. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Ampligen
Chemical structure name:poly(inosinic acid) poly(cytidylic(12), uridylic)acid



Previous:atomoxetine hydrochloride, atorvastatin calcium, Atragen, atrasentan hydrochloride, Atromid-S
Next:Augmentin, Aurimmune, Aurolate, Aurora A kinase inhibitor MLN8237, Aurora A kinase/tyrosine kinase inhibitor ENMD-2076

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov